Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPID | Q08752 | 4/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | PPIB | P23284 | 1/20 | 0.47 |
| ▸ | PPIA | P62937 | 1/20 | 0.47 |
| ▸ | PPIG | Q13427 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7946756 | 0.85 | PPID (0.62) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL16223208 | 0.82 | PPID (0.60) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL7089973 | 0.81 | GAA (0.61) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL13878757 | 0.80 | CTSK (0.49) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL8144848 | 0.79 | GAA (0.55) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL8144854 | 0.79 | GAA (0.55) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL27434109 | 0.79 | GAA (0.59) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL3042437 | 0.78 | GAA (0.53) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL7339034 | 0.77 | TET2 (0.42) | PPIDGAAMGAMSIMGAM2 | |
| SCHEMBL8042585 | 0.77 | GAA (0.54) | PPIDGAAMGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105091-A1 | Modified Amino Acids | TECHNISCHE UNIVERSITAT WIEN (AT) | 2009-04-23 | — | — | US | disclosed |
| EP-1989180-A1 | MODIFIED AMINO ACIDS | Technische Universität Wien (AT) | 2008-11-12 | — | — | EP | disclosed |
| WO-2007095980-A1 | MODIFIED AMINO ACIDS | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2007-08-30 | — | — | WO | disclosed |
| EP-1826199-A1 | Modified amino acids | Technische Universität Wien (AT) | 2007-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105091-A1 | Modified Amino Acids | SLC1A2, NR1H4, OXGR1 | PPID 283/4885GAA 3839/4885MGAM 3568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.